Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established. This study aimed to evaluate the effect of repeated rituximab courses on remission length in pemphigus vulgaris. A...

Full description

Bibliographic Details
Main Authors: Sharon Baum, Tal Raviv, Sarit Gilboa, Felix Pavlotsky, Aviv Barzilai
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2020-10-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3649